Source map — Ozempic Rival Delivers 25% Weight Loss at Highest Dose in Phase 3 Trial
Every domain this feed has drawn corroborated signal from. We store facts and short excerpts and link back to originals — never republished article bodies.
| Source | Type | Trust |
|---|---|---|
| The Guardian | news | 60% |
| Scientific American | news | 60% |
| Eli Lilly | news | 60% |
| Reuters | news | 60% |
| USA Today | news | 60% |
| Fierce Biotech | news | 60% |
| WSJ | news | 60% |
| CNBC | news | 60% |
| ScienceAlert | news | 60% |
| www.sciencealert.com | news | 50% |
| www.glp3.wiki | news | 50% |
| www.dazzr.com | news | 50% |
| shotlee.app | news | 50% |
| www.cerritosnewspaper.com | news | 50% |